Citronella Oil Pharmacology — Citronellal, Geraniol, and the Insect-Repellent Note in Medicated Oils

Citronella oil rarely headlines a medicated oil label, but it does a job none of the “classical four” — menthol, camphor, methyl salicylate, eucalyptus — can do well: it keeps insects away. In Chinese fengyoujing (风油精), Southeast Asian “mosquito oils,” Indonesian minyak telon variants, and many travel-kit liniments, citronella supplies the lemony, slightly sweet top note and the repellent function that turns a counterirritant rub into a dual-purpose product. Understanding its pharmacology means understanding two distinct plant chemotypes, a volatile-release mechanism rather than a systemic one, and a safety profile dominated not by acute toxicity but by cumulative skin irritation.

Botanical Source and the Java/Ceylon Divide

Citronella oil is steam-distilled from the leaves of tropical Cymbopogon grasses. Two commercial chemotypes dominate, and they are pharmacologically different enough that conflating them is a common error:

Citronella oil should not be confused with lemongrass oil (Cymbopogon citratus / flexuosus), whose principal constituent is citral, nor with palmarosa (Cymbopogon martinii), which is geraniol-dominant. They are botanical cousins but behave differently on skin and against insects.

Chemical Composition

A representative GC-MS profile of a Java-type oil reports citronellal (~23–45%), geraniol (~9–25%), citronellol (~10–15%), with δ-cadinene, geranyl acetate, limonene, and elemol making up much of the remainder. Three molecules carry most of the activity:

Because the oil is a mixture of volatile terpenoids, its behaviour in a medicated formulation is governed by volatility and surface release, not by depot absorption.

Mechanism 1 — Insect Repellency

Citronella does not kill insects; it repels them, and the dominant mechanism is olfactory and chemosensory rather than toxic. Volatile citronellal and geraniol form a vapour layer at the skin surface that disrupts host-seeking in mosquitoes. At the receptor level, citronellal is an agonist at insect transient receptor potential ankyrin 1 (TRPA1) channels and interferes with odorant receptor signalling, producing an avoidance response. Geraniol and linalool act through overlapping odour-masking and receptor-modulating pathways; comparative trials consistently show all three repel significantly more mosquitoes than an untreated control.

The practical limitation is short duration. Free citronella oil evaporates quickly, so unencapsulated formulations typically give meaningful protection for only 20–120 minutes depending on concentration, ambient temperature, and air movement. Higher oil concentrations and slow-release matrices (solid lipid nanoparticles, cyclodextrin inclusion complexes, polymer films) markedly extend the effect — the explicit goal of modern repellent R&D, because the same volatility that delivers the repellent vapour is what limits its working life. In a conventional medicated oil with no encapsulation, citronella’s repellent value is real but modest and requires reapplication.

Mechanism 2 — Mild Topical Analgesic and Anti-Inflammatory Action

Citronella is not a primary analgesic the way methyl salicylate or capsaicin is, but it is not inert on painful or inflamed skin either. Citronellal and citronellol show anti-inflammatory activity in animal models, with reductions in carrageenan-type oedema and downregulation of pro-inflammatory mediators reported for Cymbopogon oils. Citronellal also has documented antinociceptive effects in rodent models. Within a medicated oil, this is best understood as a supportive, secondary action layered on top of the menthol/camphor/salicylate counterirritant core — it does not justify the product on its own, but it is consistent with the traditional use of citronella-containing oils for insect bites, where the goal is simultaneous repellency, itch relief, and mild anti-inflammatory cover.

Mechanism 3 — Antimicrobial Activity

Citronella oil and its isolated constituents (geraniol, citronellol, citronellal) have broad in-vitro antibacterial and antifungal activity, including against Staphylococcus aureus, Escherichia coli, and dermatophytes. The mechanism is the typical terpenoid one: disruption of microbial membrane integrity and leakage of cellular contents. In the context of a medicated oil applied to scratched insect bites or minor abraded skin, this contributes a plausible mild antiseptic benefit, though concentrations in finished products are usually well below those used in laboratory antimicrobial assays.

Skin Absorption and Systemic Fate

Citronella’s terpenoid constituents are lipophilic and small enough to cross the stratum corneum, but the design intent in a repellent or medicated oil is the opposite of deep penetration: the active fraction should stay at or near the surface to volatilise. This is why slow-release matrices that reduce skin permeation are considered desirable. Whatever fraction is absorbed undergoes hepatic oxidation and conjugation typical of monoterpenoids and is excreted renally. Subchronic feeding studies in rats given small-to-moderate doses of geraniol or citronellol over weeks to months found no adverse effects, and regulatory reviews classify oil of citronella as showing little or no systemic toxicity at use concentrations. The meaningful risk with citronella is therefore local, not systemic.

Safety Profile: A Cumulative-Irritation and Sensitization Story

This is where citronella diverges most sharply from the bland reputation it has as a “natural” repellent.

Acute toxicity is low. Oral and dermal acute toxicity in animals is minimal at realistic exposures, and used as labelled, citronella products are not expected to harm humans.

Irritation is dose- and repetition-dependent. Single applications of diluted oil are usually well tolerated, but repeated-application studies demonstrate cumulative cutaneous toxicity — continuous application of citronella oil produces significant erythema and oedema that builds over time. This matters for medicated oils because users apply them several times a day, sometimes for days. Undiluted oil is materially more irritating; citronella should always be used at appropriate dilution in a carrier.

Allergic contact dermatitis is well documented and historically old. A follicular-type dermatitis from mosquito-protective citronella was recorded as early as 1922, and citronella appears repeatedly in the contact-dermatitis literature thereafter. Sensitization potential is chemotype-dependent: Ceylon-type oil is classed as a weak dermal sensitizer, while some local lymph node assays of citronella and the related geranium oil have returned negative results. Geraniol and citronellal are both recognised fragrance allergens and are subject to IFRA restrictions and EU fragrance-allergen labelling thresholds. The clinical signal is consistent enough that anyone with known fragrance or balsam-of-Peru allergy should treat citronella-containing oils as a likely cross-reactor.

Special populations. Some citronella products are not recommended on infants under six months without medical direction, and this caution should extend, in the medicated-oil context, to the same precautions that apply to the camphor/menthol/methyl-salicylate base: avoid the face and nostrils of infants and young children (apnoea/laryngospasm risk from camphor and menthol in those products), avoid broken or inflamed skin, and patch-test before first use. Pregnancy data for topical citronella are limited; the conservative position used elsewhere on this site — minimise essential-oil exposure especially in the first trimester and prefer products without high-dose monoterpene aldehydes — applies here too.

Role in Real Medicated Oil Formulations

Citronella’s place in the formulary is functional and well defined:

In every case the pharmacological logic is the same: citronella does not replace the counterirritant core, it extends the product’s claim space into insect repellency and bite relief while contributing minor anti-inflammatory and antimicrobial support. Its weaknesses — short repellent duration without encapsulation, and cumulative irritation on repeated use — are also the two things a careful user should plan around: reapply for sustained repellency, and do not assume “natural” means unlimited reapplication on the same patch of skin.

Practical Takeaways

This article is educational and not a substitute for medical advice. Patch-test any new medicated oil, discontinue at the first sign of rash or spreading redness, and consult a clinician for persistent skin reactions or for use in infants, pregnancy, or G6PD deficiency.